This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marchaim, D.
Right arrow Articles by Carmeli, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marchaim, D.
Right arrow Articles by Carmeli, Y.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2008, p. 1413-1418, Vol. 52, No. 4
0066-4804/08/$08.00+0     doi:10.1128/AAC.01103-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Isolation of Imipenem-Resistant Enterobacter Species: Emergence of KPC-2 Carbapenemase, Molecular Characterization, Epidemiology, and Outcomes{triangledown}

Dror Marchaim,* Shiri Navon-Venezia, Mitchell J. Schwaber, and Yehuda Carmeli

Division of Epidemiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Received 22 August 2007/ Returned for modification 31 December 2007/ Accepted 16 January 2008

The prevalence of isolation of imipenem-resistant Enterobacter (IRE) strains is rising, with potential serious consequences in terms of patients' outcomes and general care. The study objective was to define the various epidemiological aspects of the isolation of these strains in comparison to cases of isolation of imipenem-susceptible Enterobacter (ISE) strains. Molecular analysis of IRE strains included genotyping and defining the presence of carbapenemases. We conducted a matched retrospective case-control study of patients hospitalized from April 2003 to December 2006. Each IRE case was matched with an ISE case by age and source of isolation. A multivariate analysis using conditional logistic regression was performed to compare the two patient groups. There were 33 cases of IRE isolations during the study period. Twenty isolates were analyzed and found to belong to three distinct pulsotypes. Cell extracts of all of these isolates hydrolyzed imipenem. PCR and sequencing revealed that these isolates harbored a KPC-2 gene. In multivariate analysis, a high invasive-device score (P = 0.02) remained a predictor of IRE isolation. The mortality in the IRE group was 33%, compared to 9% among controls. Being an IRE case was significantly associated with increased mortality after controlling for confounders in a multivariate model (odds ratio, 8.3 ± 8.6; 95% confidence interval, 1.07 to 64; P = 0.043). Resistance to imipenem due to blaKPC-2 among Enterobacter isolates has occurred in several clones in Tel Aviv, affecting particularly patients with multiple invasive devices compared to ISE controls. IRE infections are associated with increased mortality. Enhanced measures to control the hospital spread of IRE are warranted.

* Corresponding author. Mailing address: Division of Epidemiology, Tel Aviv Sourasky Medical Center, 6 Weizmann St., Tel Aviv 64239, Israel. Phone: 972-52-3591739. Fax: 972-3-6974052. E-mail: drormc{at}netvision.net.il

{triangledown} Published ahead of print on 28 January 2008.

Antimicrobial Agents and Chemotherapy, April 2008, p. 1413-1418, Vol. 52, No. 4
0066-4804/08/$08.00+0     doi:10.1128/AAC.01103-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Stachyra, T., Levasseur, P., Pechereau, M.-C., Girard, A.-M., Claudon, M., Miossec, C., Black, M. T. (2009). In vitro activity of the {beta}-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases. J Antimicrob Chemother 0: dkp197v1-dkp197 [Abstract] [Full Text]  
  • Petersen, P. J., Jones, C. H., Venkatesan, A. M., Mansour, T. S., Projan, S. J., Bradford, P. A. (2009). Establishment of In Vitro Susceptibility Testing Methodologies and Comparative Activities of Piperacillin in Combination with the Penem {beta}-Lactamase Inhibitor BLI-489. Antimicrob. Agents Chemother. 53: 370-384 [Abstract] [Full Text]  
  • Doi, Y., Potoski, B. A., Adams-Haduch, J. M., Sidjabat, H. E., Pasculle, A. W., Paterson, D. L. (2008). Simple Disk-Based Method for Detection of Klebsiella pneumoniae Carbapenemase-Type {beta}-Lactamase by Use of a Boronic Acid Compound. J. Clin. Microbiol. 46: 4083-4086 [Abstract] [Full Text]  
  • Chmelnitsky, I., Navon-Venezia, S., Strahilevitz, J., Carmeli, Y. (2008). Plasmid-Mediated qnrB2 and Carbapenemase Gene blaKPC-2 Carried on the Same Plasmid in Carbapenem-Resistant Ciprofloxacin-Susceptible Enterobacter cloacae Isolates. Antimicrob. Agents Chemother. 52: 2962-2965 [Abstract] [Full Text]  
  • (2008). Carbapenem-Resistant Enterobacter Infections. JWatch Infect. Diseases 2008: 2-2 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»